Valaciclovir
Sold as Zelitrex, Valatrex, Varizost, Zelivire, Ran-valaciclovir, Anviro, Vavirex, Aspen valaciclovir, Hevitrex, Vorior, Voliret, Valzost, Shilova, Valaciclovir viatris, Actiprez, Valaciclovir unicorn, Jubitrex, Zelinova, Herpiva
2-[(2-Amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate
Drag to rotate. Structure from PubChem CID 135398742.
Background
Registration
- Applicants
- 16
- Registrations
- 30
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Acino Pharma (Pty) LtdCancelled | Zelitrex | 250, 500 | 290442, 320465 | S4 | None |
| Sandoz South Africa (Pty) Ltd1 of 2 cancelled | Valatrex | 250, 500 | 420340, 420341 | S4 | None |
| Trinity Pharma (Pty) Ltd | Varizost, Ran-valaciclovir | 250, 500 | 420342, 420343, 420477 | S4 | None |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Zelivire | 500 mg | 420476 | S4 | PIPIL |
| Zydus Healthcare (Pty) Ltd | Anviro | 500 | 420820 | S4 | None |
| Pharmacare limited û woodmead | Vavirex, Aspen valaciclovir | 250 mg, 500 mg | 430388, 430748, 430749 | S4 | None |
| Bliss Pharmaceuticals (Pty) Ltd | Hevitrex | Not stated | 440015 | S4 | None |
| Hetero Drugs South Africa (Pty) Ltd | Vorior | Not stated | 440016 | S4 | None |
| Aurogen South Africa (Pty) Ltd | Voliret, Shilova | 1 g, 500 mg | 450586, 450587, 450590, 450591 | S4 | None |
| Novagen Pharma (Pty) LtdCancelled | Valzost | 1 g, 500 mg | 450588, 450589 | S4 | None |
| Viatris South Africa (Pty) Ltd | Valaciclovir viatris | 250 mg, 500 mg | 450604, 450605 | S4 | None |
| Actavis Pharma (Pty) Ltd | Actiprez | 1000 | 450723 | S4 | None |
| Unicorn Pharmaceuticals (Pty) Ltd | Valaciclovir unicorn | 500 mg / 1000 mg | 490443, 490444 | S4 | PIPIL |
| Jubilant Pharma SA (Pty) Ltd | Jubitrex | 500, 500 mg and 1 000 mg | 490546, 490547 | S4 | PIPIL |
| Unimed Healthcare (Pty) Ltd | Zelinova | Not stated | 501113 | S4 | None |
| Innovata pharmaceuticals | Herpiva | 1 000, 500 | 550734, 550735 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Zelitrex 500 EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO 500 mg VALACICLOVIR | 500 | 29044229/20.2.8/0442 | Cancelled | S4 | None |
| Zelitrex 250 EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO 250,0 mg VALACICLOVIR | 250 | 32046532/20.2.8/0465 | Cancelled | S4 | None |
| Valatrex 250 EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 250,0 mg | 250 | 42034042/20.2.5/0340 | Cancelled | S4 | None |
| Valatrex 500 EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 | 42034142/20.2.5/0341 | Registered | S4 | None |
| Varizost 250 EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 250,0 mg | 250 | 42034242/20.2.8/0342 | Registered | S4 | None |
| Varizost 500 EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 | 42034342/20.2.8/0343 | Registered | S4 | None |
| Zelivire 500 EACH TABLET CONTAINS: VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 mgTablet. | 42047642/20.2.8/0476Approved 14 August 2025 | Registered | S4 | PIPIL |
| Ran-valaciclovir 500 EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 | 42047742/20.2.8/0477 | Registered | S4 | None |
| Anviro 500 tablets EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500Tablets | 42082042/20.2.8/0820 | Registered | S4 | None |
| Vavirex-500 EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 | 43038843/20.2.8/0388 | Registered | S4 | None |
| Aspen valaciclovir 250 MG EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 250,0 mg | 250 mg | 43074843/20.2.8/0748 | Registered | S4 | None |
| Aspen valaciclovir 500 MG EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 mg | 43074943/20.2.8/0749 | Registered | S4 | None |
| Hevitrex EACH TABLET CONTAINS VALACICLOVIR 500,0 mg | Not listed | 44001544/20.2.8/0015 | Registered | S4 | None |
| Vorior EACH TABLET CONTAINS VALACICLOVIR 500,0 mg | Not listed | 44001644/20.2.8/0016 | Registered | S4 | None |
| Voliret 500 MG tablets EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 mgTablets | 45058645/20.2.8/0586 | Registered | S4 | None |
| Voliret 1 g tablets EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 1,0 g | 1 gTablets | 45058745/20.2.8/0587 | Registered | S4 | None |
| Valzost 500 MG EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 mg | 45058845/20.2.8/0588 | Cancelled | S4 | None |
| Valzost 1 g EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 1,0 g | 1 g | 45058945/20.2.8/0589 | Cancelled | S4 | None |
| Shilova 500 MG tablets EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 mgTablets | 45059045/20.2.8/0590 | Registered | S4 | None |
| Shilova 1 g tablets EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 1,0 g | 1 gTablets | 45059145/20.2.8/0591 | Registered | S4 | None |
| Valaciclovir 250 MG viatris EACH TABLET CONTAINS :VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 250,0 mg | 250 mg | 45060445/20.2.8/0604 | Registered | S4 | None |
| Valaciclovir 500 MG viatris EACH TABLET CONTAINS :VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 500,0 mg | 500 mg | 45060545/20.2.8/0605 | Registered | S4 | None |
| Actiprez 1000 EACH TABLET CONTAINS VALACICLOVIR HYDROCHLORIDE EQUIVALENT TO VALACICLOVIR 1 000,0 mg | 1000 | 45072345/20.2.8/0723 | Registered | S4 | None |
| Valaciclovir 500 unicorn | 500 mg / 1000 mgFilm coated tablet | 49044349/20.2.8/0443Approved 11 August 2021 | Registered | S4 | PIPIL |
| Valaciclovir 1000 unicorn | 500 mg / 1000 mgFilm coated tablet | 49044449/20.2.8/0444Approved 11 August 2021 | Registered | S4 | PIPIL |
| Jubitrex 500 | 500Film coated tablet. | 49054649/20.2.8/0546Approved 12 May 2025 | Registered | S4 | PIPIL |
| Jubitrex 1 000 | 500 mg and 1 000 mgFilm coated tablet. | 49054749/20.2.8/0547Approved 12 May 2025 | Registered | S4 | PIPIL |
| Zelinova Each Tablet contains: Valaciclovir Hydrochloride equivalent to Valaciclovir 500 mg | Not listed | 50111350/20.2.8/1113 | Registered | S4 | None |
| Herpiva 500 EACH TABLET CONTAINS VALACICLOVIR 500,0 mg | 500 | 55073455/20.2.8/0734 | Registered | S4 | None |
| Herpiva 1 000 EACH TABLET CONTAINS VALACICLOVIR 1 000,0 mg | 1 000 | 55073555/20.2.8/0735 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Valaciclovir hydrochloride equivalent to valaciclovir
S4: Valaciclovir
Consolidated Schedules 06 July 2026, line 8340
Pharmacological class: Antiviral agents. (class 20.2.8)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Zelivire 500, Ranbaxy Pharmaceutical (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.